InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
4
T+90 胜率
33%
T+90 平均收益
+15.9%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Aballi John, 首席执行官. Officer active across 1 company, notably EXAGEN INC.. Cumulatively, 14 reports have been logged. Split: 3 buys · 4 sells. Total volume traded: €826k. History available since 16 October 2022. The latest transaction was filed on 12 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Aballi John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
150,000 股0Common StockSEC:0001843113-26-000006:0
15,698 股@ US$3.625.5% 占其流量Common StockSEC:0001843113-26-000004:0
11,430 股@ US$3.610.040% mcap4.9% 占其流量Common StockSEC:0001843113-26-000002:0
31,787 股@ US$11.81610.37% mcap45.1% 占其流量Common StockSEC:0001843113-25-000003:0
8,621 股@ US$2.4651.7% 占其流量Common StockSEC:0001274737-25-000013:0
112,500 股0Common StockSEC:0001274737-25-000010:0
24,305 股@ US$2.815.4% 占其流量Common StockSEC:0001274737-24-000094:0
标准退出：2025年2月12日 (T+90)
40,401 股@ US$1.926.0% 占其流量Common StockSEC:0001274737-24-000052:0
标准退出：2024年8月14日 (T+90)
9,804 股@ US$1.911.5% 占其流量Common StockSEC:0001274737-24-000015:0
175,000 股0Common StockSEC:0001274737-24-000012:0
33,819 股@ US$1.74514.7% 占其流量Common StockSEC:0001274737-23-000094:0
9,803 股@ US$2.1421.6% 占其流量Common StockSEC:0001274737-23-000091:0
90,000 股@ US$2.6819.3% 占其流量Common StockSEC:0001274737-22-000083:0
标准退出：2023年3月8日 (T+90)
350,000 股0Restricted Stock UnitsSEC:0001843113-22-000010:0
14 条申报中的 14 条
About Aballi John
John Aballi is the President and Chief Executive Officer of EXAGEN INC. He leads the company in developing diagnostic solutions, aiming to enhance healthcare. His expertise in business and technology is an asset for EXAGEN.
